The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

Study results have validated that five routinely measured clinical values reliably identified patients with type 2 diabetes who had significantly different A1c responses to two important classes of ...

Researchers and physicians have designed a method to help people with type 1 diabetes better manage their glucose levels. The method relies upon artificial intelligence and automated monitoring.

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...

Objective To conduct a systematic review of cost-effectiveness, cost-utility, and cost-benefit studies of DPP-4 inhibitors for diabetes treatment versus other antidiabetics. Methods Three ...

Researchers and physicians at Oregon Health & Science University, using artificial intelligence and automated monitoring, have designed a method to help people with type 1 diabetes better manage their ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

If you’ve been diagnosed with cancer and you have diabetes, you should know that cancer treatments can have a strong effect on your blood sugar. It can be tricky to navigate the two conditions at the ...

Maturity-onset diabetes of the young (MODY) is an autosomal dominant monogenic form of diabetes. This report describes a case with hepatocyte nuclear factor 1-alpha ( HNF1A )-MODY due to a novel ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...